PATENT CLAIM ANALYSIS

Application Number: 15994934
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to a method for treating degenerative neurological disorders in a subject in need thereof, comprising administering to a subject in need thereof a therapeutically effective amount of a composition comprising an acid sphingomyelinase (ASM) activity inhibitor or expression inhibitor as an active ingredient.

Claim (Index 5):
The method of  claim 2 , wherein the ASM activity inhibitor is an antibody specifically binding to ASM protein.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 93.0
- Lexical Diversity: 1.34211
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14889293', '15417315', '15313642', '14550025', '14289996']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7637055929324483
- 35 USC 102 Novelty (BERT): 0.5712462767567439
- Combined Prediction Score: 0.744459661314878
- Mean Citation Score: 350.576054
- Max Citation Score: 522.7991
- Similarity Product: 308.77369382332563

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test